Insider Transactions Reported by 8 Insiders of Lomond Therapeutics Holdings, Inc.

Location
Dover, DE

There are no Buy or Sell transactions made by insiders since 14 Mar 2025

Lomond Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eilean Therapeutics, LLC 10%+ Owner $57,681,532 01 Nov 2024
Carl L. Gordon Director $10,709,024 01 Nov 2024
ORBIMED ADVISORS LLC Director $10,709,024 01 Nov 2024
Nikolay Savchuk President and COO, Director $10,709,024 01 Nov 2024
Mark N. Tompkins Former Director $4,800,000 01 Nov 2024
Ian Seth Jacobs Former Director and officer $700,000 01 Nov 2024
Iain D. Dukes CEO and Chairman, Director 01 Nov 2024
Eddie Wang Rodriguez Director 01 Nov 2024

Recent Insider Transactions by Companies or Individuals for Lomond Therapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Mark N. Tompkins Common Stock Other -74.7% -3,550,000 1,200,000 01 Nov 2024 Direct
Ian Seth Jacobs Common Stock Other -30% -75,000 175,000 01 Nov 2024 Direct
Orbimed Advisors Llc Common Stock Award 117% 1,443,750 2,677,256 01 Nov 2024 See Footnote
Orbimed Advisors Llc Common Stock Conversion of derivative security 1,233,506 1,233,506 01 Nov 2024 See Footnote
Orbimed Advisors Llc Simple Agreement for Future Equity Conversion of derivative security -100% -1,233,506 0 01 Nov 2024 See Footnote
Carl L. Gordon Common Stock Award 117% 1,443,750 2,677,256 01 Nov 2024 See Footnote
Carl L. Gordon Common Stock Conversion of derivative security 1,233,506 1,233,506 01 Nov 2024 See Footnote
Carl L. Gordon Simple Agreement for Future Equity Conversion of derivative security -100% -1,233,506 0 01 Nov 2024 See Footnote
Nikolay Savchuk Common Stock Award 117% 1,443,750 2,677,256 01 Nov 2024 By TPAV, LLC
Nikolay Savchuk Common Stock Conversion of derivative security 1,233,506 1,233,506 01 Nov 2024 By TPAV, LLC
Nikolay Savchuk Simple Agreement for Future Equity Conversion of derivative security 1,233,506 0 01 Nov 2024 By TPAV, LLC
Nikolay Savchuk Stock Option (Right to Buy) Award 1,258,000 1,258,000 01 Nov 2024 Direct
Iain D. Dukes Stock Option (Right to Buy) Award 2,096,667 2,096,667 01 Nov 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.